Soon after the discovery of highly pathogenic avian influenza (HPAI) strain H5N1 in dairy cattle, scientists learned that ...

Regenxbio's RGX-202 gene therapy shows promising results in Duchenne muscular dystrophy, with high microdystrophin levels and ...

In a recent case study, researchers from North Carolina State University found Bartonella henselae, Babesia odocoilei and ...

D-150 is a potential backbone therapy that is designed to provide multi-year sustained delivery of anti-VEGF (aflibercept and ...

The following is a summary of “Automated Imaging Differentiation for Parkinsonism,” published in the March 2025 issue of JAMA ...

A vaccine against norovirus, the dreaded “winter vomiting bug”, could be closer than you think: early clinical trials have ...

Danon disease is a rare but serious cardiomyopathy that drastically reduces life expectancy. Male patients infrequently live ...

"This is a historic moment for 4DMT as we become a Phase 3 company following our initiation of the 4FRONT-1 clinical trial,” said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.

Rob Truesdell discusses how enterprises must rethink data security in the age of AI. He explores why traditional security tools fall short as companies ...

A new orally administered norovirus vaccine tablet has demonstrated promising safety and immunogenicity in older adults.

In a new case study, researchers from North Carolina State University found Bartonella henselae, Babesia odocoilei and ...

BARCELONA, Spain I March 13, 2025 I SpliceBio, a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations ...